Literature DB >> 22371912

Clinical and genetic analysis of three Korean children with pyridoxine-dependent epilepsy.

Sook Hyun Nam1, Min-Jung Kwon, Jeehun Lee, Cha Gon Lee, Hee Joon Yu, Chang-Seok Ki, Munhyang Lee.   

Abstract

Pyridoxine-dependent epilepsy (PDE) is a rare autosomal recessive disorder that causes intractable seizures, especially in neonates and infants. Patients are typically resistant to typical antiepileptic drugs (AEDs) but respond dramatically to pyridoxine. Mutations in the ALDH7A1 gene are associated with the pathogenesis of PDE. Herein, we report the clinical phenotypes and disease-causative mutations in the ALDH7A1 gene in three Korean patients with PDE. We reviewed the medical records, electroencephalography (EEG), brain magnetic resonance imaging (MRI) findings, and the results of molecular genetic tests for the patients who were diagnosed with PDE in our institution between Jan. 1996 and Dec. 2010. In all patients, the first seizures began during the first week of life. The seizures were not fully controlled with multiple AEDs, but disappeared immediately after administration of pyridoxine and returned after it was transiently discontinued. Before the use of pyridoxine, interictal EEGs showed multifocal epileptiform discharges, which became normalized with pyridoxine. Direct sequencing analyses revealed two mutant alleles in all three patients. Patient 1 was compound heterozygous with two different missense mutations, c.1061A>G (p.Y354C) and c.1232C>T (p.P411L). Patient 2 was homozygous for a missense mutation, c.1279G>C (p.E427Q). Patient 3 was compound heterozygous for two different missense mutations, c.1061A>G (p.Y354C) and c.1279G>C (p.E427Q), and her parents and younger brother were heterozygous carriers of each one of the mutations. All three mutations had not previously been reported. Herein, we report three Korean patients with three novel mutations who presented with PDE.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22371912

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  6 in total

1.  Plasma Pyridoxal 5´-Phosphate Level in Children with Intractable and Controlled Epilepsy.

Authors:  Zahra Pirzadeh; Mohammad Ghofrani; Mohsen Mollamohammadi
Journal:  Iran J Child Neurol       Date:  2017

2.  Analysis of the Phenotypic Variability as Well as Impact of Early Diagnosis and Treatment in Six Affected Families With ALDH7A1 Deficiency.

Authors:  Xianru Jiao; Pan Gong; Ye Wu; Yuehua Zhang; Zhixian Yang
Journal:  Front Genet       Date:  2021-04-01       Impact factor: 4.599

3.  A case for newborn screening for pyridoxine-dependent epilepsy.

Authors:  Curtis R Coughlin; Laura A Tseng; Clara D M van Karnebeek
Journal:  Cold Spring Harb Mol Case Stud       Date:  2022-03-24

4.  Clinical diagnosis, treatment, and ALDH7A1 mutations in pyridoxine-dependent epilepsy in three Chinese infants.

Authors:  Zhixian Yang; Xiaoling Yang; Ye Wu; Jingmin Wang; Yuehua Zhang; Hui Xiong; Yuwu Jiang; Jiong Qin
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

5.  Clinical and genetic characteristics of pyridoxine-dependent epilepsy: Case series report of three Chinese patients with phenotypic variability.

Authors:  Sanmei Wang; Jing Sun; Yao Tu; Lina Zhu; Zhichun Feng
Journal:  Exp Ther Med       Date:  2017-07-09       Impact factor: 2.447

6.  Prenatal genetic testing in 19 fetuses with corpus callosum abnormality.

Authors:  Qin She; Erfang Tang; Cui Peng; Li Wang; Dandan Wang; Weihe Tan
Journal:  J Clin Lab Anal       Date:  2021-09-27       Impact factor: 2.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.